Search research articles
Contact Us
Filters
Showing results (161-170 of 183) with videos related to
Page
of 19
Sort By:
Ultrasound International Open
|
September 20, 2023
Caesarean Scar Pregnancy: Single Dose of Intrasac Ultrasound-Guided Methotrexate Injection Seems to be a Safe Option for Treatment
Angeliki Rouvalis, Panagiotis Vlastarakos, Georgios Daskalakis, et al.
Oncotargets and Therapy
|
August 1, 2015
Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?
Aris Giannos, Martin Filipits, Flora Zagouri, et al.
International Journal of Cancer
|
March 30, 2011
VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2
Apostolos C Ziogas, Nikos G Gavalas, Marinos Tsiatas, et al.
Gynecologic Oncology
|
November 27, 2007
Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy
Aristotelis Bamias, Vasiliki Koutsoukou, Evangelos Terpos, et al.
Human Reproduction Open
|
February 9, 2023
ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma<sup></sup>
Alexandros Rodolakis, Giovanni Scambia, François Planchamp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 6, 2023
ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
Alexandros Rodolakis, Giovanni Scambia, François Planchamp, et al.
Gynecologic Oncology
|
March 17, 2020
Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy
Michalis Liontos, Maria Sotiropoulou, Maria Kaparelou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 14, 2020
JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer
Tina Bagratuni, Nefeli Mavrianou, Nikolaos G Gavalas, et al.
BMC Cancer
|
December 14, 2018
Management of uterine sarcomas and prognostic indicators: real world data from a single-institution
Anastasios Kyriazoglou, Michael Liontos, Dimitrios C Ziogas, et al.
Current Oncology (Toronto, Ont.)
|
December 13, 2021
<i>BRCA1/2</i> Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients
Michalis Liontos, Eleni Zografos, Panagiotis Zoumpourlis, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 183) with videos related to
Sort By:
Page
of 19
Ultrasound International Open
|
September 20, 2023
Caesarean Scar Pregnancy: Single Dose of Intrasac Ultrasound-Guided Methotrexate Injection Seems to be a Safe Option for Treatment
Angeliki Rouvalis, Panagiotis Vlastarakos, Georgios Daskalakis, et al.
Oncotargets and Therapy
|
August 1, 2015
Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?
Aris Giannos, Martin Filipits, Flora Zagouri, et al.
International Journal of Cancer
|
March 30, 2011
VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2
Apostolos C Ziogas, Nikos G Gavalas, Marinos Tsiatas, et al.
Gynecologic Oncology
|
November 27, 2007
Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy
Aristotelis Bamias, Vasiliki Koutsoukou, Evangelos Terpos, et al.
Human Reproduction Open
|
February 9, 2023
ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma<sup></sup>
Alexandros Rodolakis, Giovanni Scambia, François Planchamp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 6, 2023
ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
Alexandros Rodolakis, Giovanni Scambia, François Planchamp, et al.
Gynecologic Oncology
|
March 17, 2020
Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy
Michalis Liontos, Maria Sotiropoulou, Maria Kaparelou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 14, 2020
JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer
Tina Bagratuni, Nefeli Mavrianou, Nikolaos G Gavalas, et al.
BMC Cancer
|
December 14, 2018
Management of uterine sarcomas and prognostic indicators: real world data from a single-institution
Anastasios Kyriazoglou, Michael Liontos, Dimitrios C Ziogas, et al.
Current Oncology (Toronto, Ont.)
|
December 13, 2021
<i>BRCA1/2</i> Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients
Michalis Liontos, Eleni Zografos, Panagiotis Zoumpourlis, et al.
Page
of 19